Page 52 - Immunization Practices News Today

Respiratory syncytial virus (RSV) is an infectious respiratory disease that can look and sound a lot like a cold, with coughing, sneezing and a runny nose.

The agency's decision on Monday sets up shots to be rolled out later this month.

The U.S. drug regulator authorized updated COVID-19 vaccines from Pfizer and its partner BioNTech as well as from Moderna on Monday as the country prepares to start an autumn vaccination campaign as soon as this week. The U.S. Food and Drug Administration approved the shots for those aged 12 and above, and authorized them for emergency use in children aged 6 months through 11 years. Advisers to the U.S. Centers for Disease Control and Prevention are set to meet on Tuesday to discuss recommenda...

MONDAY, Sept. 11, 2023 (HealthDay News) -- The U.S. Food and Drug Administration on Monday gave the green light to new COVID boosters for Americans, setting the stage for the

The CDC will decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or for everyone.

The FDA today authorized the newest COVID-19 vaccine, the first not to target the initial or ancestral strain of the virus.

The new shots are similar to previously approved formulas but were updated to target strains of the virus descended from Omicron.

The updated vaccines are intended to target newer variants of COVID-19 and are expected to available "in the near future."

There's still some debate within the medical community about whether everyone stands to benefit substantially from another COVID booster shot.

New single-strain vaccines will exclusively target the XBB.1.5 Omicron subvariant